Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDR | P35968 | 10/20 | 0.63 |
| ▸ | BTK | Q06187 | 1/20 | 0.55 |
| ▸ | AURKA | O14965 | 2/20 | 0.51 |
| ▸ | AURKB | Q96GD4 | 2/20 | 0.51 |
| ▸ | EGFR | P00533 | 7/20 | 0.49 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.49 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.49 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17675189 | 0.88 | KDR (0.63) | KDRBTKAURKAAURKBEGFR | |
| SCHEMBL17683762 | 0.87 | BTK (0.62) | KDRBTKEGFRMAPK14ERBB2 | |
| SCHEMBL17675397 | 0.86 | BTK (0.70) | KDRBTKAURKAAURKBEGFR | |
| SCHEMBL17675602 | 0.78 | BTK (0.76) | KDRBTKAURKAAURKBEGFR | |
| SCHEMBL17675257 | 0.74 | EGFR (0.72) | KDRBTKAURKAAURKBEGFR | |
| SCHEMBL17683708 | 0.74 | BTK (0.76) | KDRBTKEGFRMAPK14ERBB2 | |
| SCHEMBL17675322 | 0.73 | BTK (0.83) | KDRBTKEGFRERBB2 | |
| SCHEMBL17683840 | 0.73 | BTK (0.79) | KDRBTKEGFRERBB2 | |
| SCHEMBL17675433 | 0.73 | KDR (0.59) | KDRMAPK14 | |
| SCHEMBL31067608 | 0.72 | KDR (0.85) | KDRAURKAAURKBEGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2016055982-A1 | QUINOLINE AND QUINAZOLINE COMPOUNDS | ACERTA PHARMA B.V. (NL) | 2016-04-14 | — | — | WO | claimed |